1. Partial agonist and biased signalling properties of the synthetic enantiomers J113863/UCB35625 at chemokine receptors CCR2 and CCR5
- Author
-
Jenny Corbisier, Marc Parmentier, Céline Galés, Alexandre Huszagh, and Jean-Yves Springael
- Subjects
0301 basic medicine ,CCR1 ,Agonist ,Receptors, CCR5 ,Receptors, CCR2 ,medicine.drug_class ,G protein ,Mutation, Missense ,Biotechnologie ,CHO Cells ,GTP-Binding Protein alpha Subunits, Gi-Go ,Biology ,Biochemistry ,Partial agonist ,03 medical and health sciences ,Chemokine receptor ,Cricetulus ,0302 clinical medicine ,Cell Movement ,Cricetinae ,parasitic diseases ,Functional selectivity ,medicine ,Animals ,Humans ,Inverse agonist ,Receptor ,Molecular Biology ,Cell Biology ,beta-Arrestin 2 ,Sciences biomédicales ,Cell biology ,030104 developmental biology ,Amino Acid Substitution ,Xanthenes ,Sciences pharmaceutiques ,030217 neurology & neurosurgery ,Protein Binding ,Signal Transduction - Abstract
Biased agonism at G protein-coupled receptors constitutes a promising area of research for the identification of new therapeutic molecules. In this study we identified two novel biased ligands for the chemokine receptors CCR2 and CCR5 and characterized their functional properties. We showed that J113863 and its enantiomer UCB35625, initially identified as high affinity antagonists for CCR1 and CCR3, also bind with low affinity to the closely related receptors CCR2 and CCR5. Binding of J113863 and UCB35625 to CCR2 or CCR5 resulted in the full or partial activation of the three Gi proteins and the two Go isoforms. Unlike chemokines, the compounds did not activate G12. Binding of J113863 to CCR2 or CCR5 also induced the recruitment of -arrestin 2, whereas UCB35625 did not. UCB35625 induced the chemotaxis of L1.2 cells expressing CCR2 or CCR5. In contrast, J113863 induced the migration of L1.2-CCR2 cells but antagonized the chemokine-induced migration of L1.2- CCR5 cells. We also showed that replacing the phenylalanine 3.33 in CCR5 TM3 by the corresponding histidine of CCR2 converts J113863 from an antagonist for cell migration and a partial agonist in other assays to a full agonist in all assays. Further analyses indicated that F3.33H substitution strongly increased the activation of G proteins and β-arrestin 2 by J113863. These results highlight the biased nature of the J113863 and UCB35625 that act either as antagonist, partial agonist, or full agonist according to the receptor, the enantiomer, and the signaling pathway investigated., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2017